Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same

Clin Infect Dis. 1994 May;18(5):793-8. doi: 10.1093/clinids/18.5.793.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use
  • Bone Marrow Transplantation / adverse effects
  • Hematopoietic Cell Growth Factors / therapeutic use
  • Humans
  • Immunocompromised Host
  • Immunologic Factors / therapeutic use
  • Immunosuppression Therapy / adverse effects
  • Leukocyte Transfusion
  • Mycoses / drug therapy
  • Mycoses / epidemiology
  • Mycoses / etiology*
  • Neoplasms / complications
  • Neoplasms / drug therapy
  • Neutropenia / chemically induced
  • Neutropenia / classification
  • Neutropenia / complications*
  • Neutropenia / prevention & control
  • Risk Factors
  • Superinfection
  • Survival Rate

Substances

  • Adrenal Cortex Hormones
  • Antibiotics, Antineoplastic
  • Hematopoietic Cell Growth Factors
  • Immunologic Factors